GOODWILL AND INTANGIBLE ASSETS

12 Months Ended

Dec. 29, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Our two reportable segments, Healthcare and Business Solutions, are also our reporting units for purposes of goodwill impairment testing. We performed the annual impairment test of goodwill for all our reporting units in the second quarter of 2013 following a quantitative approach. No goodwill impairment was noted. The following table summarizes the allocation of goodwill following our reorganization in 2012 and our 2013 acquisition of WorkflowOne.



	Healthcare		Business Solutions		Financial Services			Commercial			Industrial			Total
Goodwill at January 1, 2012	$	3,284	$	—	$	1,743		$	1,296		$	1,133		$	7,456
Reallocation of goodwill	—		4,172		(1,743		)	(1,296		)	(1,133		)	—
Goodwill at December 30, 2012	3,284		4,172		—			—			—			7,456
Acquisition	19,787		51,391		—			—			—			71,178
Goodwill at December 29, 2013	$	23,071	$	55,563	$	—		$	—		$	—		$	78,634

Identifiable intangible assets consist of the following:



	December 29, 2013					December 30, 2012
	Gross Carrying Amount		Accumulated Amortization			Gross Carrying Amount		Accumulated Amortization
Intangible Assets with Determinable Lives
Customer relationships	$	47,710	$	(4,355	)	$	2,610	$	(783	)
Trademarks	8,629		(745		)	129		(28		)
Patents	2,916		(1,193		)	2,916		(1,042		)
Software technology	2,650		(946		)	2,650		(568		)
Favorable lease agreements	140		(24		)	—		—
Non-compete agreement	100		(72		)	100		(51		)
Total	$	62,145	$	(7,335	)	$	8,405	$	(2,472	)

Amortization expense for intangible assets was $4,863, $1,090, and $631 for 2013, 2012, and 2011. Estimated amortization expense for the next five years is as follows: $10,110 in 2014, $9,637 in 2015, $8,966 in 2016, $8,966 in 2017, and $8,767 in 2018.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details